According to GlobalData, GSD is one of 108 product lines sold in the US covid-19 tests market; these product lines are sold by 60 different manufacturers. The price of the GSD device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Gold Standard Diagnostics apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Gold Standard Diagnostics overview
Gold Standard Diagnostics, Inc. (GSDX) is engaged in development and sale of various instruments such as analyzers and processors and is also involved in offering comprehensive diagnostic solutions that in turn improves lab efficiencies and minimize overall costs of its users. It also offers lab support, product development, engineering, manufacturing and distribution related services for its customers. The company is headquartered in California, the US.
For a complete picture of GSD, COVID-19 Tests pricing in the US, buy the report here.